Cancer Immunotherapy Market
Cancer Immunotherapy Market - Global Industry Assessment & Forecast
#
Pages:
197
Base Year:
2023
Jun - 2024
Format:
Report Code:
VMR-2509
Segments Covered
By
Product Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies & Cancer Vaccines
-
By
Application Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head & Neck Cancer, Ovarian Cancer, Pancreatic Cancer, Other Cancers
-
By
Distribution Channel Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
-
By
End Use Hospitals & Clinics, Cancer Research Centers, Other End Uses
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2023 |
| Forecast
Years:
|
2024 - 2032 |
 Historical
Years:
|
2018 - 2022 |
 Revenue
2023: |
USD 121.2 Billion |
 Revenue 2032:
|
USD 245.37 Billion |
 Revenue CAGR
(2024 - 2032): |
8.15% |
Fastest Growing Region (2024 -
2032)
|
Asia Pacific |
Largest Region (2023):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Cancer Immunotherapy Market Segment Analysis
- Cancer Immunotherapy Product Outlook (Revenue, USD Million, 2018 - 2030)
- Monoclonal Antibodies
- Immunomodulators
- Oncolytic Viral Therapies & Cancer Vaccines
- Cancer Immunotherapy Application Outlook (Revenue, USD Million, 2018 - 2030)
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Melanoma
- Prostate Cancer
- Head & Neck Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Other Cancers
- Cancer Immunotherapy Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Cancer Immunotherapy End Use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals & Clinics
- Cancer Research Centers
- Other End Uses
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Cancer Immunotherapy Market, by Product
- Monoclonal Antibodies
- Immunomodulators
- Oncolytic Viral Therapies & Cancer Vaccines
-
North America Cancer Immunotherapy Market, by Application
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Melanoma
- Prostate Cancer
- Head & Neck Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Other Cancers
-
North America Cancer Immunotherapy Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
-
North America Cancer Immunotherapy Market, by End Use
- Hospitals & Clinics
- Cancer Research Centers
- Other End Uses
- U.S.
- U.S. Cancer Immunotherapy Market, by Product
- Monoclonal Antibodies
- Immunomodulators
- Oncolytic Viral Therapies & Cancer Vaccines
- U.S. Cancer Immunotherapy Market, by Application
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Melanoma
- Prostate Cancer
- Head & Neck Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Other Cancers
- U.S. Cancer Immunotherapy Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- U.S. Cancer Immunotherapy Market, by End Use
- Hospitals & Clinics
- Cancer Research Centers
- Other End Uses
- U.S. Cancer Immunotherapy Market, by Product
- Canada
- Canada Cancer Immunotherapy Market, by Product
- Monoclonal Antibodies
- Immunomodulators
- Oncolytic Viral Therapies & Cancer Vaccines
- Canada Cancer Immunotherapy Market, by Application
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Melanoma
- Prostate Cancer
- Head & Neck Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Other Cancers
- Canada Cancer Immunotherapy Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Canada Cancer Immunotherapy Market, by End Use
- Hospitals & Clinics
- Cancer Research Centers
- Other End Uses
- Canada Cancer Immunotherapy Market, by Product
-
Mexico
- Mexico Cancer Immunotherapy Market, by Product
- Monoclonal Antibodies
- Immunomodulators
- Oncolytic Viral Therapies & Cancer Vaccines
- Mexico Cancer Immunotherapy Market, by Application
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Melanoma
- Prostate Cancer
- Head & Neck Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Other Cancers
- Mexico Cancer Immunotherapy Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Mexico Cancer Immunotherapy Market, by End Use
- Hospitals & Clinics
- Cancer Research Centers
- Other End Uses
- Mexico Cancer Immunotherapy Market, by Product
-
North America Cancer Immunotherapy Market, by Product
- Europe
-
Europe Cancer Immunotherapy Market, by Product
- Monoclonal Antibodies
- Immunomodulators
- Oncolytic Viral Therapies & Cancer Vaccines
-
Europe Cancer Immunotherapy Market, by Application
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Melanoma
- Prostate Cancer
- Head & Neck Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Other Cancers
-
Europe Cancer Immunotherapy Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
-
Europe Cancer Immunotherapy Market, by End Use
- Hospitals & Clinics
- Cancer Research Centers
- Other End Uses
- U. K.
- U.K. Cancer Immunotherapy Market, by Product
- Monoclonal Antibodies
- Immunomodulators
- Oncolytic Viral Therapies & Cancer Vaccines
- U.K. Cancer Immunotherapy Market, by Application
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Melanoma
- Prostate Cancer
- Head & Neck Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Other Cancers
- U.K. Cancer Immunotherapy Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- U.K. Cancer Immunotherapy Market, by End Use
- Hospitals & Clinics
- Cancer Research Centers
- Other End Uses
- U.K. Cancer Immunotherapy Market, by Product
- France
- France Cancer Immunotherapy Market, by Product
- Monoclonal Antibodies
- Immunomodulators
- Oncolytic Viral Therapies & Cancer Vaccines
- France Cancer Immunotherapy Market, by Application
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Melanoma
- Prostate Cancer
- Head & Neck Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Other Cancers
- France Cancer Immunotherapy Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- France Cancer Immunotherapy Market, by End Use
- Hospitals & Clinics
- Cancer Research Centers
- Other End Uses
- France Cancer Immunotherapy Market, by Product
-
Germany
- Germany Cancer Immunotherapy Market, by Product
- Monoclonal Antibodies
- Immunomodulators
- Oncolytic Viral Therapies & Cancer Vaccines
- Germany Cancer Immunotherapy Market, by Application
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Melanoma
- Prostate Cancer
- Head & Neck Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Other Cancers
- Germany Cancer Immunotherapy Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Germany Cancer Immunotherapy Market, by End Use
- Hospitals & Clinics
- Cancer Research Centers
- Other End Uses
- Germany Cancer Immunotherapy Market, by Product
-
Italy
- Italy Cancer Immunotherapy Market, by Product
- Monoclonal Antibodies
- Immunomodulators
- Oncolytic Viral Therapies & Cancer Vaccines
- Italy Cancer Immunotherapy Market, by Application
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Melanoma
- Prostate Cancer
- Head & Neck Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Other Cancers
- Italy Cancer Immunotherapy Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Italy Cancer Immunotherapy Market, by End Use
- Hospitals & Clinics
- Cancer Research Centers
- Other End Uses
- Italy Cancer Immunotherapy Market, by Product
-
Spain
- Spain Cancer Immunotherapy Market, by Product
- Monoclonal Antibodies
- Immunomodulators
- Oncolytic Viral Therapies & Cancer Vaccines
- Spain Cancer Immunotherapy Market, by Application
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Melanoma
- Prostate Cancer
- Head & Neck Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Other Cancers
- Spain Cancer Immunotherapy Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Spain Cancer Immunotherapy Market, by End Use
- Hospitals & Clinics
- Cancer Research Centers
- Other End Uses
- Spain Cancer Immunotherapy Market, by Product
-
Rest of Europe
- Rest of Europe Cancer Immunotherapy Market, by Product
- Monoclonal Antibodies
- Immunomodulators
- Oncolytic Viral Therapies & Cancer Vaccines
- Rest of Europe Cancer Immunotherapy Market, by Application
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Melanoma
- Prostate Cancer
- Head & Neck Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Other Cancers
- Rest of Europe Cancer Immunotherapy Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Rest of Europe Cancer Immunotherapy Market, by End Use
- Hospitals & Clinics
- Cancer Research Centers
- Other End Uses
- Rest of Europe Cancer Immunotherapy Market, by Product
-
Europe Cancer Immunotherapy Market, by Product
- Asia Pacific
-
Asia Pacific Cancer Immunotherapy Market, by Product
- Monoclonal Antibodies
- Immunomodulators
- Oncolytic Viral Therapies & Cancer Vaccines
-
Asia Pacific Cancer Immunotherapy Market, by Application
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Melanoma
- Prostate Cancer
- Head & Neck Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Other Cancers
-
Asia Pacific Cancer Immunotherapy Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
-
Asia Pacific Cancer Immunotherapy Market, by End Use
- Hospitals & Clinics
- Cancer Research Centers
- Other End Uses
- China
- China Cancer Immunotherapy Market, by Product
- Monoclonal Antibodies
- Immunomodulators
- Oncolytic Viral Therapies & Cancer Vaccines
- China Cancer Immunotherapy Market, by Application
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Melanoma
- Prostate Cancer
- Head & Neck Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Other Cancers
- China Cancer Immunotherapy Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- China Cancer Immunotherapy Market, by End Use
- Hospitals & Clinics
- Cancer Research Centers
- Other End Uses
- China Cancer Immunotherapy Market, by Product
- Japan
- Japan Cancer Immunotherapy Market, by Product
- Monoclonal Antibodies
- Immunomodulators
- Oncolytic Viral Therapies & Cancer Vaccines
- Japan Cancer Immunotherapy Market, by Application
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Melanoma
- Prostate Cancer
- Head & Neck Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Other Cancers
- Japan Cancer Immunotherapy Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Japan Cancer Immunotherapy Market, by End Use
- Hospitals & Clinics
- Cancer Research Centers
- Other End Uses
- Japan Cancer Immunotherapy Market, by Product
-
Germany
- Germany Cancer Immunotherapy Market, by Product
- Monoclonal Antibodies
- Immunomodulators
- Oncolytic Viral Therapies & Cancer Vaccines
- Germany Cancer Immunotherapy Market, by Application
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Melanoma
- Prostate Cancer
- Head & Neck Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Other Cancers
- Germany Cancer Immunotherapy Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Germany Cancer Immunotherapy Market, by End Use
- Hospitals & Clinics
- Cancer Research Centers
- Other End Uses
- Germany Cancer Immunotherapy Market, by Product
-
India
- India Cancer Immunotherapy Market, by Product
- Monoclonal Antibodies
- Immunomodulators
- Oncolytic Viral Therapies & Cancer Vaccines
- India Cancer Immunotherapy Market, by Application
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Melanoma
- Prostate Cancer
- Head & Neck Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Other Cancers
- India Cancer Immunotherapy Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- India Cancer Immunotherapy Market, by End Use
- Hospitals & Clinics
- Cancer Research Centers
- Other End Uses
- India Cancer Immunotherapy Market, by Product
-
South Korea
- South Korea Cancer Immunotherapy Market, by Product
- Monoclonal Antibodies
- Immunomodulators
- Oncolytic Viral Therapies & Cancer Vaccines
- South Korea Cancer Immunotherapy Market, by Application
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Melanoma
- Prostate Cancer
- Head & Neck Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Other Cancers
- South Korea Cancer Immunotherapy Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- South Korea Cancer Immunotherapy Market, by End Use
- Hospitals & Clinics
- Cancer Research Centers
- Other End Uses
- South Korea Cancer Immunotherapy Market, by Product
-
South East Asia
- South East Asia Cancer Immunotherapy Market, by Product
- Monoclonal Antibodies
- Immunomodulators
- Oncolytic Viral Therapies & Cancer Vaccines
- South East Asia Cancer Immunotherapy Market, by Application
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Melanoma
- Prostate Cancer
- Head & Neck Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Other Cancers
- South East Asia Cancer Immunotherapy Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- South East Asia Cancer Immunotherapy Market, by End Use
- Hospitals & Clinics
- Cancer Research Centers
- Other End Uses
- South East Asia Cancer Immunotherapy Market, by Product
-
Rest of Asia Pacific
- Rest of Asia Pacific Cancer Immunotherapy Market, by Product
- Monoclonal Antibodies
- Immunomodulators
- Oncolytic Viral Therapies & Cancer Vaccines
- Rest of Asia Pacific Cancer Immunotherapy Market, by Application
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Melanoma
- Prostate Cancer
- Head & Neck Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Other Cancers
- Rest of Asia Pacific Cancer Immunotherapy Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Rest of Asia Pacific Cancer Immunotherapy Market, by End Use
- Hospitals & Clinics
- Cancer Research Centers
- Other End Uses
- Rest of Asia Pacific Cancer Immunotherapy Market, by Product
-
Asia Pacific Cancer Immunotherapy Market, by Product
- Latin America
-
Latin America Cancer Immunotherapy Market, by Product
- Monoclonal Antibodies
- Immunomodulators
- Oncolytic Viral Therapies & Cancer Vaccines
-
Latin America Cancer Immunotherapy Market, by Application
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Melanoma
- Prostate Cancer
- Head & Neck Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Other Cancers
-
Latin America Cancer Immunotherapy Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
-
Latin America Cancer Immunotherapy Market, by End Use
- Hospitals & Clinics
- Cancer Research Centers
- Other End Uses
- Brazil
- Brazil Cancer Immunotherapy Market, by Product
- Monoclonal Antibodies
- Immunomodulators
- Oncolytic Viral Therapies & Cancer Vaccines
- Brazil Cancer Immunotherapy Market, by Application
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Melanoma
- Prostate Cancer
- Head & Neck Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Other Cancers
- Brazil Cancer Immunotherapy Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Brazil Cancer Immunotherapy Market, by End Use
- Hospitals & Clinics
- Cancer Research Centers
- Other End Uses
- Brazil Cancer Immunotherapy Market, by Product
- Argentina
- Argentina Cancer Immunotherapy Market, by Product
- Monoclonal Antibodies
- Immunomodulators
- Oncolytic Viral Therapies & Cancer Vaccines
- Argentina Cancer Immunotherapy Market, by Application
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Melanoma
- Prostate Cancer
- Head & Neck Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Other Cancers
- Argentina Cancer Immunotherapy Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Argentina Cancer Immunotherapy Market, by End Use
- Hospitals & Clinics
- Cancer Research Centers
- Other End Uses
- Argentina Cancer Immunotherapy Market, by Product
-
Rest of Latin America
- Rest of Latin America Cancer Immunotherapy Market, by Product
- Monoclonal Antibodies
- Immunomodulators
- Oncolytic Viral Therapies & Cancer Vaccines
- Rest of Latin America Cancer Immunotherapy Market, by Application
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Melanoma
- Prostate Cancer
- Head & Neck Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Other Cancers
- Rest of Latin America Cancer Immunotherapy Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Rest of Latin America Cancer Immunotherapy Market, by End Use
- Hospitals & Clinics
- Cancer Research Centers
- Other End Uses
- Rest of Latin America Cancer Immunotherapy Market, by Product
-
Latin America Cancer Immunotherapy Market, by Product
- Middle East & Africa
-
Middle East & Africa Cancer Immunotherapy Market, by Product
- Monoclonal Antibodies
- Immunomodulators
- Oncolytic Viral Therapies & Cancer Vaccines
-
Middle East & Africa Cancer Immunotherapy Market, by Application
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Melanoma
- Prostate Cancer
- Head & Neck Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Other Cancers
-
Middle East & Africa Cancer Immunotherapy Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
-
Middle East & Africa Cancer Immunotherapy Market, by End Use
- Hospitals & Clinics
- Cancer Research Centers
- Other End Uses
- GCC Countries
- GCC Countries Cancer Immunotherapy Market, by Product
- Monoclonal Antibodies
- Immunomodulators
- Oncolytic Viral Therapies & Cancer Vaccines
- GCC Countries Cancer Immunotherapy Market, by Application
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Melanoma
- Prostate Cancer
- Head & Neck Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Other Cancers
- GCC Countries Cancer Immunotherapy Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- GCC Countries Cancer Immunotherapy Market, by End Use
- Hospitals & Clinics
- Cancer Research Centers
- Other End Uses
- GCC Countries Cancer Immunotherapy Market, by Product
- South Africa
- South Africa Cancer Immunotherapy Market, by Product
- Monoclonal Antibodies
- Immunomodulators
- Oncolytic Viral Therapies & Cancer Vaccines
- South Africa Cancer Immunotherapy Market, by Application
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Melanoma
- Prostate Cancer
- Head & Neck Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Other Cancers
- South Africa Cancer Immunotherapy Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- South Africa Cancer Immunotherapy Market, by End Use
- Hospitals & Clinics
- Cancer Research Centers
- Other End Uses
- South Africa Cancer Immunotherapy Market, by Product
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Cancer Immunotherapy Market, by Product
- Monoclonal Antibodies
- Immunomodulators
- Oncolytic Viral Therapies & Cancer Vaccines
- Rest of Middle East & Africa Cancer Immunotherapy Market, by Application
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Melanoma
- Prostate Cancer
- Head & Neck Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Other Cancers
- Rest of Middle East & Africa Cancer Immunotherapy Market, by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Rest of Middle East & Africa Cancer Immunotherapy Market, by End Use
- Hospitals & Clinics
- Cancer Research Centers
- Other End Uses
- Rest of Middle East & Africa Cancer Immunotherapy Market, by Product
-
Middle East & Africa Cancer Immunotherapy Market, by Product
- North America
Vantage Market
Research | 03-Jul-2024
FAQ
Frequently Asked Question
What is the global demand for Cancer Immunotherapy in terms of revenue?
-
The global Cancer Immunotherapy valued at USD 121.2 Billion in 2023 and is expected to reach USD 245.37 Billion in 2032 growing at a CAGR of 8.15%.
Which are the prominent players in the market?
-
The prominent players in the market are AstraZeneca (UK), Merck & Co. Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Immunocore Ltd. (UK), Pfizer Inc. (U.S.), Bristol-Myers Squibb Company (U.S.), Novartis AG (Switzerland), Eli Lilly & Company (U.S.), Johnson & Johnson Services Inc. (U.S.).
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 8.15% between 2024 and 2032.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Cancer Immunotherapy include
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Cancer Immunotherapy in 2023.
